Clinical Trial Update: Radioimmunotherapy With 90Y Zevalin for Orbital Lymphoma [NA]

View source ↗

Summary

This clinical trial studied radioimmunotherapy with 90Y Zevalin for orbital lymphoma and has completed, with results posted in 2013.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Lymphoma
• Non-hodgkin Lymphoma

Drugs mentioned

• Zevalin (ibritumomab tiuxetan)

Snippet

Sponsor: M.D. Anderson Cancer Center | Conditions: Non-Hodgkin's Lymphoma, Lymphoma | NA | Status: COMPLETED | Results posted: 2013-11-18